Md. Judge Dismisses Manufacturing Defect, Consumer Protection Act Claims in Humira Case

BALTIMORE — A Maryland federal judge has dismissed a manufacturing defect claim against Abbott Laboratories Inc. (NYSE: ABT) in a Humira case, finding it was not pleaded with the requisite specificity.

On Jan. 16, Judge James K. Bredar of the U.S. District Court for the District of Maryland also dismissed a claim for violation of the Maryland Consumer Protection Act, finding it does not meet the act’s causation standard.

Elizabeth Pease and her husband sued Abbott, alleging that Pease was injured by her ingestion of Humira. Abbott moved to dismiss the counts of strict liability for manufacturing defect and violation …